These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 11914997)

  • 21. Early biomarker activity in severe sepsis and septic shock and a contemporary review of immunotherapy trials: not a time to give up, but to give it earlier.
    Rivers EP; Jaehne AK; Nguyen HB; Papamatheakis DG; Singer D; Yang JJ; Brown S; Klausner H
    Shock; 2013 Feb; 39(2):127-37. PubMed ID: 23324881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment options for severe sepsis and septic shock.
    Sharma VK; Dellinger RP
    Expert Rev Anti Infect Ther; 2006 Jun; 4(3):395-403. PubMed ID: 16771617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sepsis and septic shock in pregnancy.
    Sheffield JS
    Crit Care Clin; 2004 Oct; 20(4):651-60; viii. PubMed ID: 15388194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mediator-specific therapies for the systemic inflammatory response syndrome, sepsis, severe sepsis, and septic shock: present and future approaches.
    Hazinski MF
    Crit Care Nurs Clin North Am; 1994 Jun; 6(2):309-19. PubMed ID: 7946190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sepsis: time has come to focus on the later stages.
    Schefold JC; Hasper D; Volk HD; Reinke P
    Med Hypotheses; 2008 Aug; 71(2):203-8. PubMed ID: 18448264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality.
    Nguyen HB; Corbett SW; Steele R; Banta J; Clark RT; Hayes SR; Edwards J; Cho TW; Wittlake WA
    Crit Care Med; 2007 Apr; 35(4):1105-12. PubMed ID: 17334251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mortality predictions using current physiologic scoring systems in patients meeting criteria for early goal-directed therapy and the severe sepsis resuscitation bundle.
    Nguyen HB; Banta JE; Cho TW; Van Ginkel C; Burroughs K; Wittlake WA; Corbett SW
    Shock; 2008 Jul; 30(1):23-8. PubMed ID: 18323748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reducing mortality in severe sepsis: the Surviving Sepsis Campaign.
    Townsend SR; Schorr C; Levy MM; Dellinger RP
    Clin Chest Med; 2008 Dec; 29(4):721-33, x. PubMed ID: 18954706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of life of survivors from severe sepsis and septic shock may be similar to that of others who survive critical illness.
    Granja C; Dias C; Costa-Pereira A; Sarmento A
    Crit Care; 2004 Apr; 8(2):R91-8. PubMed ID: 15025783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early goal-directed therapy, corticosteroid, and recombinant human activated protein C for the treatment of severe sepsis and septic shock in the emergency department.
    Nguyen HB; Corbett SW; Menes K; Cho T; Daugharthy J; Klein W; Wittlake WA
    Acad Emerg Med; 2006 Jan; 13(1):109-13. PubMed ID: 16365336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sepsis in the critically-ill patient].
    Christensen VB; Nielsen JS; Tønnesen EK
    Ugeskr Laeger; 2007 Feb; 169(8):703-5. PubMed ID: 17313921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Septic shock: new pharmacotherapy options or better trial design?
    Vincent JL; Van Nuffelen M
    Expert Opin Pharmacother; 2013 Apr; 14(5):561-70. PubMed ID: 23452102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antithrombin therapy of no value in sepsis according to a large clinical trial].
    Gårdlund B
    Lakartidningen; 2002 Mar; 99(13):1456-7, 1460. PubMed ID: 11989356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sepsis: time to reconsider the concept.
    Carlet J; Cohen J; Calandra T; Opal SM; Masur H
    Crit Care Med; 2008 Mar; 36(3):964-6. PubMed ID: 18431286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. More evidence that timing matters in the treatment of patients with sepsis.
    Sevransky J
    Crit Care Med; 2008 Oct; 36(10):2932-3. PubMed ID: 18812795
    [No Abstract]   [Full Text] [Related]  

  • 36. The outcome of patients with sepsis and septic shock presenting to emergency departments in Australia and New Zealand.
    ;
    Crit Care Resusc; 2007 Mar; 9(1):8-18. PubMed ID: 17352661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving outcomes for severe sepsis and septic shock: tools for early identification of at-risk patients and treatment protocol implementation.
    Rivers EP; Ahrens T
    Crit Care Clin; 2008 Jul; 24(3 Suppl):S1-47. PubMed ID: 18634996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The future is predetermined in severe sepsis, so what are the implications?
    Lukaszewicz AC; Payen D
    Crit Care Med; 2010 Oct; 38(10 Suppl):S512-7. PubMed ID: 21164390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of severe sepsis and septic shock in critically ill patients.
    Namendys-Silva SA; Hernández-Garay M
    Heart Lung; 2012; 41(4):408-9. PubMed ID: 22534210
    [No Abstract]   [Full Text] [Related]  

  • 40. Possible interventional therapies in severe sepsis or septic shock.
    Wu CC
    Acta Anaesthesiol Taiwan; 2012 Jun; 50(2):74-7. PubMed ID: 22769862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.